| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/16/2009 | CN101601687A Preparation method of disappearance powder for uremi |
| 12/16/2009 | CN101601686A Chinese medicinal preparation for treating hemorrhoids and preparation method thereof |
| 12/16/2009 | CN101601640A Cocoon sericin layer alcohol soluble substance and preparation method thereof |
| 12/16/2009 | CN100569942C Alpha-N-acetyl galactosamine enzyme and encode gene and applications thereof |
| 12/16/2009 | CN100569936C Acanthopanax-root wine and its production method |
| 12/16/2009 | CN100569297C Gene transfer-mediated angiogenesis therapy |
| 12/16/2009 | CN100569287C Immunoglobulin for dog intravenous injection, its preparing method and the formulation thereof |
| 12/16/2009 | CN100569283C Calcium-tablet for preventing osteoporosis |
| 12/16/2009 | CN100569282C Injection bone peptide freeze-drying preparation and its making method |
| 12/16/2009 | CN100569280C External applied medicine for treating lumbar vertebra, cervical vertebra and osteoarthrilis |
| 12/16/2009 | CN100569278C Chinese medicine combination for activating blood circulation and treating thrombus |
| 12/16/2009 | CN100569277C Effervescence tablet for treating colpitis, preparation method and use thereof |
| 12/16/2009 | CN100569273C External application Chinese medicine for treating dermatoma, tinea, wart and herpes |
| 12/16/2009 | CN100569272C Antibiotic vagina protection washing liquid and its preparing method |
| 12/16/2009 | CN100569264C Compound Chinese aloe tablet and preparation thereof |
| 12/16/2009 | CN100569252C Medicne for treating primary hypertension and its preparation method |
| 12/16/2009 | CN100569248C Pharmaceutical composition for treating paralysis |
| 12/16/2009 | CN100569247C Chinese medicine composition for strengthening the body resistance and tonifying the liver, preparation and use thereof |
| 12/16/2009 | CN100569243C Preparation method of coagulated bacillus living formulation for treating ulcerative colitis and application thereof |
| 12/16/2009 | CN100569222C Pearl kuding tea lozenge |
| 12/16/2009 | CN100569114C Crocodile meat preparation and production process thereof |
| 12/16/2009 | CN100569085C Method for preparing sour milk containing nano-antler and ants with tonifying-Yang and eliminating fatigue functions |
| 12/16/2009 | CN100569071C Process for frozen-preserving Chinese sturgeon semen under super-low temperature |
| 12/15/2009 | US7632980 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems |
| 12/15/2009 | US7632818 Method for treating conditions associated with the Metabolic Syndrome (Syndrome X) |
| 12/15/2009 | US7632680 Differentiating the obtained central nervous system (CNS) stem cells by culturing stems cells in vitro in differentiation medium containing fibroblast growth factor 8 and glial cell line derived neurotrophic factor, transplanting them into CNS |
| 12/15/2009 | US7632679 Systems and methods for screening for modulators of neural differentiation |
| 12/15/2009 | US7632522 Use of stinging cells/capsules for the delivery of active agents to keratinous substances |
| 12/15/2009 | US7632520 Contains Cefixime Trihydrate, Cloxacillin Sodium (sustained release and immediate release form), Lactobacillus sporogenes spores |
| 12/15/2009 | US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections |
| 12/15/2009 | CA2469684C Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation |
| 12/15/2009 | CA2361635C Methods and compositions for healing and repair of articular cartilage |
| 12/15/2009 | CA2269096C Method for in vitro preconditioning of myoblasts before transplantation |
| 12/15/2009 | CA2255614C Dha-pharmaceutical agent conjugates |
| 12/15/2009 | CA2237118C Liquid colostrum for dairy products |
| 12/15/2009 | CA2226833C Adenovirus vectors for gene therapy |
| 12/15/2009 | CA2175319C Use of bovine colostrum extract in mouth-care products |
| 12/15/2009 | CA2139168C Food supplements for very young kids |
| 12/10/2009 | WO2009149303A1 Fviii muteins for treatment of von willebrand disease |
| 12/10/2009 | WO2009148568A1 Human facilitating cells |
| 12/10/2009 | WO2009148488A2 Use of oncolytic herpes viruses for killing cancer stem cells |
| 12/10/2009 | WO2009148294A1 Extract from the skin of rana catesbeiana, compound and method for treating mastitis in cattle |
| 12/10/2009 | WO2009148137A1 Nucleic acid capable of controlling degranulation of mast cell |
| 12/10/2009 | WO2009148058A1 Process for production of microcapsules by use of solid fat |
| 12/10/2009 | WO2009147702A1 Cerebroprotective agent |
| 12/10/2009 | WO2009147455A2 Method of differentiated development of genetic cells in a substratum autologous - heterologous targeted fixation cryopreservation bank of regenerated fluid tissues - tissues |
| 12/10/2009 | WO2009146750A1 Anti-cancer immune-modulating agent |
| 12/10/2009 | WO2009127971A3 Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria |
| 12/10/2009 | WO2009114504A3 Reducing conjugative plasmids in bacteria |
| 12/10/2009 | US20090307788 Ribozyme mediated stabilization of polynucleotides |
| 12/10/2009 | US20090305418 Cell therapy method for the treatment of tumors |
| 12/10/2009 | US20090305405 Use of tgf beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells |
| 12/10/2009 | US20090305344 Chimeric alphavirus replicon particles |
| 12/10/2009 | US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases |
| 12/10/2009 | US20090304808 Anti-cancer immune-modulating agent |
| 12/10/2009 | US20090304807 Method for preparing a prion-free bond grafting substitute |
| 12/10/2009 | US20090304788 Encapsulated materials and methods for encapsulating materials |
| 12/10/2009 | US20090304780 Wound dressings incorporating honey |
| 12/10/2009 | US20090304774 Implantable devices having ceramic coating applied via an atomic layer deposition method |
| 12/10/2009 | US20090304749 Method of Producing Rough Strains of Bacteria and Uses Thereof |
| 12/10/2009 | US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein |
| 12/10/2009 | US20090304677 Extracorporeal Removal of Microvesicular Particles |
| 12/10/2009 | US20090304660 G-csf derivative for inducing immunological tolerance |
| 12/10/2009 | US20090304659 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+ t cells |
| 12/10/2009 | US20090304658 Method of proliferating lak cell |
| 12/10/2009 | US20090304657 Chimeric t cell receptors and related materials and methods of use |
| 12/10/2009 | US20090304656 Controlled activation of the reuterin-production machinery of lactobacillus |
| 12/10/2009 | US20090304655 Infant formula with probiotics |
| 12/10/2009 | US20090304652 Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells |
| 12/10/2009 | US20090304651 Insulin-Like Growth Factor II (IGF-II) Binding Factors |
| 12/10/2009 | US20090304650 Repair of the Bone Marrow Vasculature |
| 12/10/2009 | US20090304648 Mast Cell Stabilizers to Prevent or Treat Laminitis |
| 12/10/2009 | US20090304646 Multipotent/Pluripotent Cells and Methods |
| 12/10/2009 | US20090304645 In vitro engineered, regenerated urinary tract tissue compositions and methods for producing same |
| 12/10/2009 | US20090304644 Systems and methods for manipulation of regenerative cells separated and concentrated from adipose tissue |
| 12/10/2009 | US20090304643 Methods of Preparing and Characterizing Mesenchymal Stem Cell Aggregates and Uses Thereof |
| 12/10/2009 | US20090304642 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates |
| 12/10/2009 | US20090304641 Methods and Compositions for Regulating Gene Expression |
| 12/10/2009 | US20090304640 Transfection of Collagen-Producing Cells |
| 12/10/2009 | US20090304638 Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water |
| 12/10/2009 | US20090304637 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy |
| 12/10/2009 | US20090304636 Stem Cell Factor Therapy for Tissue Injury |
| 12/10/2009 | US20090304588 Biologically excitable cells |
| 12/10/2009 | US20090301363 Self-contained Heating Unit and Drug-Supply Unit Employing Same |
| 12/10/2009 | CA2726804A1 Xbp1, cd138, and cs1 peptides |
| 12/10/2009 | CA2726341A1 Human facilitating cells |
| 12/10/2009 | CA2726193A1 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 12/09/2009 | EP2130915A1 Cell capable of expressing lacritin at high level |
| 12/09/2009 | EP2130545A2 Solution and tincture |
| 12/09/2009 | EP2130543A1 Method for decreasing borborygmi by administering a bifidobacterium bacteria |
| 12/09/2009 | EP2129775A1 Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
| 12/09/2009 | EP2129774A1 Cells for heart treatment |
| 12/09/2009 | EP2129386A1 Probiotics for reduction of risk of obesity |
| 12/09/2009 | EP2129384A2 Composition containing autologous mononuclear cells and scaffold and its use in the preparation of a surgical medicament |
| 12/09/2009 | EP2129216A1 Production of a viable, storable worm egg suspension |
| 12/09/2009 | EP1694707B1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 12/09/2009 | EP1648493B1 Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
| 12/09/2009 | EP1534819B1 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 12/09/2009 | EP1040198B1 Recombinant rhabdovirus containing a heterologous fusion protein |